Peel Hunt analysts have provided a short update on Faron Pharmaceuticals Limited (AIM:FARN) after the AIM-listed company announced plans to meet with the US Food & Drug Administration earlier than planned in the hope of fast-tracking its lead drug bexmarilimab.
Faron’s incoming chief executive Juho Jalkanen has cited this as a key priority.
Atome has received a punchy share price target of 130p from analysts at Canaccord, which sees the firm as a potential leader in the transition towards electricity-based fertiliser production.
Aim-listed Atome focuses on transforming low-cost electricity into clean, cost-effective, high-value fertiliser using a unique production process that uses electricity, water, and air instead of natural gas, enhancing the cost efficiency, security of supply, and sustainability of its fertiliser products.
Accesso, the ticketing and virtual queuing specialist, trades at a discount to both US SaaS and UK SaaS/IT services peers, says broker Shore Capital something that it sees as unwarranted.
Results for 2023 were ahead of indications while, since the end of the year, the company has culled its lower margin B2C distribution business.
JPMorgan Chase & Co (NYSE:JPM, ETR:CMC)’s respected chief executive Jamie Dimon may be something of a cryptocurrency permabear, but some analysts at the Wall Street institution have a positive read on the state of the bitcoin mining market right now.
Bitcoins’ price has taken a tumble recently, just as the hotly anticipated Halving event approaches later this week when bitcoin’s distribution rate will be cut in half as part of a four-year cycle.
accesso Technology Group, the ticketing and virtual queuing group, said it had seen good early take-up of Freedom, a new product for the restaurant and retail sector.
“We have seen encouraging early demand and a growing pipeline which will expand our reach into the hospitality market,” said Steve Brown, chief executive.
NextEnergy Solar Fund Ltd (LSE:NESF) has successfully refinanced its £135 million short-term revolving credit facility (RCF), extending the maturity by two years.
This refinancing includes the option for two additional 12-month extensions, potentially taking the facility up to June 2028.
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) has been granted a US patent for its pioneering use of Xenon magnetic resonance imaging (MRI) in cardiopulmonary blood flow imaging.
This development marks a significant advancement in the diagnosis and monitoring of pulmonary vascular diseases (PVD), which affect the network of blood vessels connecting the lungs to the heart.
Iofina produced 123.7 metric tonnes (M') of crystalline iodine from its six plants in Oklahoma in the first three months of 2024, up 15.5% from a year ago.
Powerhouse Energy Group PLC (AIM:PHE) has completed an important phase in the development of its Feedstock Testing Unit (FTU), manufacturing a new 2.5 tonne per day kiln.
The kiln, made by AGICO in China, was shipped on April 15 and its expected to arrive at the Powerhouse Technical Centre in Bridgend after about 45 days.
Baron Oil PLC (AIM:BOIL) told investors it has successfully completed a site survey at its Chuditch-2 appraisal well location, in the Democratic Republic of Timor-Leste.
The survey concluded under the approved budget, the company added.
Faron Pharmaceuticals Limited (AIM:FARN) said it plans to meet with the US Food & Drug Administration earlier than planned in the hope of fast-tracking its lead drug, which has shown huge promise in treating a type of rare blood cancer.
This is one of the key priorities of the incoming CEO, Dr Juho Jalkanen, set out in an update issued on Tuesday.
Rainbow Rare Earths said test results from its second project in Brazil suggest eventually might be larger than the Phalaborwa development in South Africa, its current main focus.
Mineralogy and hydrometallurgical studies carried out on phosphogypsum material from the Uberaba site showed the highest grades came from the most recently deposited phosphogypsum material at between 4,520 to 7,912ppm total rare earth oxides (TREO).